tiagabine hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
7 FDA-registered drug labelers
Cephalon, LLC
MAHI DRUGS PRIVATE LIMITED
MSN Life Sciences Private Limited
Novadoz Pharmaceuticals LLC
Siegfried Malta Limited
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceuticals USA, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Tiagabine Hydrochloride
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Tiagabine Hydrochloride Tablet
04/15/2026Chemical Identity
CAS145821-59-6
PubChem CID91274
DTXSIDDTXSID2044218
FormulaC20H26ClNO2S2
Mol. Weight412 g/mol
SMILESCC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl
Data Sources
912742026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tiagabine hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/tiagabine hydrochloride.json
CAS 145821-59-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 145821-59-62026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json